Showing results (781-790 of 20,010) with videos related to
Sort By:
Pageof 2,001
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Burnout in radiation therapists: the predictive value of selected stressorsDuane Akroyd, Amy Caison, Robert D AdamsInternational Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Multiparameter fluorescence mapping of nonprotein sulfhydryl status in relation to blood vessels and hypoxia in cervical carcinoma xenograftsVojislav Vukovic, Trudey Nicklee, David W HedleyInternational Journal of Radiation Oncology, Biology, Physics|February 19, 2002
The effect of high-dose-rate brachytherapy dwell sequence on cell survivalMark R Arnfield, Peck Sun Lin, Matthew A Manning, et al.International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Hyperfractionation as an effective way of overcoming radioresistanceJ Denekamp, A Daşu, A Waites, et al.International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Temporal changes in PO2 of R3230AC tumors in Fischer-344 ratsM W Dewhirst, R D Braun, J L LanzenInternational Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Studies of 99mTc-BnAO (HL-91): a non-nitroaromatic compound for hypoxic cell detectionX Zhang, T Melo, J R Ballinger, et al.International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Bioreductive therapies: an overview of drugs and their mechanisms of actionA M Rauth, T Melo, V MisraInternational Journal of Radiation Oncology, Biology, Physics|December 9, 1998
NLCQ-1, a novel hypoxic cytotoxin: potentiation of melphalan, cisDDP and cyclophosphamide in vivoM V Papadopoulou, M Ji, W D BloomerInternational Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Effects of SN-38 (an active metabolite of CPT-11) on responses of human and rodent cells to irradiationK Sasai, G Z Guo, K Shibuya, et al.International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancerC P Cottrill, K Bishop, M I Walton, et al.Pageof 2,001